Login
Navigate Fool.com
Will UTHR beat
the market?
Community Rating: 4 Stars: Favorite

93.50 -0.13 (-0.14%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $94.51
Previous Close $93.63
Daily Range $91.02 - $94.68
52-Week Range $59.05 - $116.65
Market Cap $4.7B
P/E Ratio 28.55
Dividend (Yield) $0.00 (0.0%)
Volume 1,077,284
Average Daily Volume 877,740
Current FY EPS $6.93

How do you think UTHR
will perform against the market?

Top UTHR Bull/Bear Pitches

 

Turtlebale (< 20)
Submitted June 6, 2011

negative response to clinical data is an overreaction

0 Replies Reply Report this Post
 

cnbr1 (0)
Submitted October 4, 2006

New PAH drugs will reduce UTHR's market; generic Flolan, Ambrisentan etc.

0 Replies Reply Report this Post

News & Commentary Rss Feed

Today’s Top Biotech Stories: Insmed, Exelixis, United Therapeutics, and Alnylam

Insmed, Exelixis, United Therapeutics, and Alnylam could all make biotech headlines this morning. Here’s why.

XBI, MNKD, UTHR, ARNA: Large Inflows Detected at ETF

Healthcare Stocks Ending Near Session Lows; United Therapeutics Up 3% After Standpoint Touts Market-

Healthcare Stocks Ending Near Session Lows; United Therapeutics Up 3% After Standpoint Touts Market-Leading Position

Sector Update: Healthcare

Interesting UTHR Put And Call Options For November 22nd

Catalysts That Could Push Top Biotech Stocks Even Higher

InterMune Stuns Markets, but Is It Overvalued?

Trial results for Intermune's Esbriet launched shares higher this month; however, the opportunity may not justify shares heading much higher from here.

First Week of April 19th Options Trading For United Therapeutics (UTHR)

Revenue Growth + Sane Valuation: Making A List

Chelsea's Northera Gets Another Chance

A January advisory panel meeting and potential FDA approval in February could move the needle for this small biotech.

See More UTHR News...

Sector

Healthcare

Industry

Drugs

United Therapeutics Corp (UTHR) Description

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. Website: http://www.unither.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks